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Abstract 
Staphylococcus epidermidis has developed from a skin and mucus commensal to an 
opportunistic pathogen, and is frequently causing infections in medical implants. Its ability to 
form biofilm on implant surfaces makes these infections extremely persistent, and re-
operation is in most cases the only option to clear these infections. Quorum-sensing, chemical 
cell-to-cell communication between bacteria has shown to regulate several virulence factors in 
important pathogens, such as biofilm formation and toxin production. Molecules with the 
ability to quench this quorum sensing could therefore lead to new therapies, targeting traits 
crucial for bacterial pathogenesis. Thiophenones are quorum sensing inhibitors, showing 
ability to inhibit AI-2 mediated communication. When using thiophenones a decrease in 
biofilm formation in Vibrio harveyi, Escherichia coli and S.epidermidis has been observed.
 The aim of this study was to investigate the effect of different thiophenones on 
virulence factors in S.epidermidis. The effect of thiophenones on S.epidermidis biofilm 
formation in combination with antibiotics was tested, as well as persister cell formation and 
adherence to eukaryotic cells. An in vivo model for studying Staphylococcal infections was 
also established using C.elegans. This model was used to look at the effect of a thiophenone 
on recovery of C.elegans after infection.       
 All thiophenones tested showed inhibition of AI-2 communication in V.harveyi in a 
bioluminescence assay. Thiophenones in combination with antibiotics did not show to have 
any additive effect on S.epidermidis biofilm formation. To isolate and test the effect of 
thiophenones on persister cells proved difficult, and no conclusion regarding the effect of 
thiophenones could be drawn. S.epidermidis showed low binding to Caco-2 cells, and it was 
therefore difficult to determine if thiophenones had any effect on the ability to bind to 
eukaryotic cells. Two S.epidermidis strains and one S.aureus strain was tested for their ability 
to cause infection in C.elegans. Only worms grown on S.aureus showed decreased survival 
after 7 days of infection. The effect of a thiophenone on C.elegans recovery from 24 h 
infection by S.aureus was tested, but no persistent infection was detected. It was therefore 
difficult to make any conclusion about the effect of thiophenone on recovery, but the 
thiophenone concentration was shown not to be toxic for the worms.   
 Optimization of the different methods is needed to make any conclusions on 
thiophenones effect on the different virulence factors in S.epidermidis.    
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Agr Accessory gene regulator 
AHL Acyl-homoserine lactone 
AIP Autoinducer peptide 
AI-2 Autoinducer-2 
BA Bioluminescence assay media 
BHI Brain heart infusion 
BSIs Nosocomial blood stream infections 
C.elegans Caenorhabditis elegans 
CFU Colony forming unit 
CoNS Coagulase-negative Staphylococci 
DPD 4,5-dihydroxy-2,3-pentanedione 
E.coli Escherichia coli 
HAIs Healthcare-Associated Infections 
HI Heart infusion  
MIC Minimal inhibitory concentration 
MRSA Methicillin-resistant Staphylococcus aureus 
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NGM Nematode growth medium 
PBP Penicillin binding protein 
PBS Phosphate-buffered saline 
PIA Polysaccharide intercellular adhesin 
QS Quorum sensing 
SAM S-adenosylmethionine 
S.aureus Staphylococcus aureus 
SCCmec The staphylococcal cassette chromosome mec 
S.epidermidis Staphylococcus epidermidis 
TF Thiophenones 
TSA Tryptic soy agar 
TSB Tryptic soy broth 
V.harveyi Vibrio harveyi 
w/o Without 
2.5 P Optimized Buffered Peptone Water 
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1 Introduction 
1.1 Staphylococcus epidermidis  
Staphylococcus epidermidis (S.epidermidis) is a gram positive and coagulase negative 
bacterium. Coagulase-negative staphylococci are often collectively termed CoNS (or CNS), 
with S.epidermidis being the clinically most important of these (1-3). S.epidermidis has 
primarily been regarded as an innocent skin and mucosal commensal living on healthy human 
skin, but with medical progress leading to widespread use of indwelling medical devices it 
has developed into an opportunistic pathogen (3). S.epidermidis usually only cause infection 
in immuno-compromised patients or patients undergoing surgery, and is therefore a frequent 
cause of nosocomial infections (4). CoNS alone account for 11.4% of all healthcare-
associated infections (HAIs) in the US and 31% of all nosocomial bloodstream infections 
(BSIs) (5, 6). Joint arthroplasties, left ventricular assist devices, intravascular catheters and 
cardiac pacemakers are just some of the medical devices offering new surfaces for the 
bacteria to colonize (2, 7, 8).         
 The reasons for the resilience of S.epidermidis infections are several. One of them is 
the ability to grow in thick agglomerations called biofilm on both biotic and abiotic surfaces, 
which makes the infection much more persistent (9, 10). Biofilm growth makes the bacteria 
up to a 1000- fold more tolerant to antimicrobials than planktonic grown cells (11, 12), and 
provides protection from components of the hosts immune system (13). Another issue is that a 
high percentage of S.epidermidis isolated from clinical settings carries methicillin resistance 
genes which also provide resistance toward other β-lactam antibiotics (14, 15). Resistance 
towards other classes of often used antibiotics also seems to be spreading among the clinical 
isolated strains (16, 17). The fact that the infections are difficult to clear with antibiotics leads 
to prolonged hospital stays and re-operation is in most cases the only option to clear the 
infection (2, 18).  The prolonged hospital stays for the patient and the need for new surgery 
has great economic impacts. Alone periprosthetic joint infections caused by methicillin-
resistant staphylococci have been calculated to have a cost of $107 264 per case in the US, 
and with an expected number of 3.5 million total joint arthroplasties carried out by 2030, the 
costs are enormous and increasing (7).  
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1.2 Pathogenicity and virulence factors 
The pathogenicity of bacteria is their ability to cause disease in a host. To accomplish this 
they require some virulence factors which here will be defined as “genes and proteins that 
facilitate the establishment of infection and persistence of the organism in the human body” 
(10). Common virulence factors among pathogens are invasion, production of toxins, serum 
resistance, motility and antiphagocytic mechanisms (19).      
 With S.epidermidis not being a specialized pathogen, but a regular skin and mucosal 
commensal, the key virulence factors are also important for the commensal lifestyle (10).  
1.2.1 Biofilms  
The main virulence factor of S. epidermidis is the ability to form biofilm (4). A biofilm is a 3-
dimensional agglomeration of bacterial cells on a surface, enclosed in a matrix composed of 
exopolysaccharides, proteins and extracellular DNA (eDNA) (20, 21). Bacterial biofilms are 
responsible for as much as 65% of infections in developed countries, and are in many cases 
the cause of persistent infections such as endocarditis, pneumonia in cystic fibrosis patients, 
infections related to orthopedic devices, contact lenses and urinary and central venous 
catheters (21-23). As briefly mentioned above, S.epidermidis can form biofilm both on abiotic 
surfaces such as indwelling devices as well as on biotic surfaces such as living tissue. 
Biofilm-growth is advantageous both for a skin commensal and for an opportunistic pathogen, 
because it provides protection from environmental stress, being scraped or washed away and 
also from host immune system components (24). The 3-dimensional appearance is not the 
only factor that separate the nature of planktonic and biofilm forming bacteria. There has also 
been found great differences in the gene expression. S.epidermidis in biofilm have been found 
to down regulate genes for transcription, translation and aerobic metabolism and up-
regulating genes favoring fermentation and also expression of osmoprotective factors 
especially important  for its commensal lifestyle on human skin (25). As more knowledge 
about the structure of biofilm is obtained, the more of its complexity is revealed.  
 S.epidermidis is one of the best studied clinically relevant biofilm-forming bacterium 
and there is therefore a fair amount of knowledge available about the biofilm formation 
process (26). The formation of biofilm can be viewed as a three-stage process starting with 
attachment, followed by maturation of the biofilm and finally detachment of bacterial cells 
(Fig.1) (9, 26). The primary step in the attachment is adhesion of the bacteria to a surface-
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material and is normally a nonspecific process relying on forces between the surface material 
and the surface of the bacterial cell, such as hydrophobic interactions between polyethylene 
plastic and the bacteria (27, 28). When an implant or an indwelling medical device is inserted 
into the body, it quickly gets coated with host matrix proteins that serve as receptors for the 
bacteria (24). Adhesion to these proteins is probably the most important factor in initial 
attachment. S.epidermidis expresses a variety of adhesins called MSCRAMMs (microbial 
surface components recognizing adhesive matrix molecules) that have the ability to bind to 
host matrix proteins like fibronectin, vitronectin, fibrinogen and collagen (29, 30). In addition, 
proteins mediating adherence directly to both the surface material and matrix proteins have 
been identified, like the autolysin AtlE witch mediates attachment to a polystyrene surface 
and also binds to vitronectin (31). Thus, it is likely that the ability to bind to both host matrix 
proteins and directly to surface polymers is an important function for the pathogenesis of 
S.epidermidis, and a significant trait making them the supreme colonizer of indwelling 
devices.          
 Biofilm maturation involves intercellular adhesion between the bacteria forming large 
cell clusters, and disruptive processes leading to the structuring of the biofilm (24). The most 
important molecule in the adhesion process in S.epidermidis is PIA, for polysaccharide 
intercellular adhesin, synthesized by the products of the IcaADBC operon (32-34). PIA 
synthesis has been shown to be an important factor for other clinically significant traits 
important for biofilm assembly. It has been shown that PIA-producing strains have higher 
adherence to host cells than a mutant strain unable to produce PIA and that the PIA-producing 
strain also had a higher tolerance to antibiotics (35).  In addition, it has been demonstrated 
that PIA production protects S.epidermidis from components of the innate immune system 
like phagocytosis and antibacterial peptides (36). The other important step in the maturation 
process is structuring of the biofilm. The structuring of the biofilm is dependent on disruptive 
processes leading to the formation of the “mushroom”-like structure and complex structures 
like fluid filled channels for exchange of nutrient and metabolic waste products (37, 38). 
 The final step in biofilm life cycle is detachment of single cells or clusters of bacteria 
from the biofilm. This process is dependent on parts of the matrix detaching from the rest of 
the biofilm, for instance through mechanical forces or enzymatic activity breaking down 
matrix molecules (26). The detachment process in S.epidermidis seems to be regulated by the 
accessory gene regulator quorum sensing system agr (39). It has been shown that agr mutants 
produce a thicker biofilm and is less invasive than biofilm produced by wild type, because agr 
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is involved in regulating the detachment process (40). Detachment leads to dispersal of the 
infection through the blood-stream causing sepsis or re-colonization and the formation of 
biofilm on a second site in the body (24).       
 
Figure 1: The formation of biofilm in Staphylococcus epidermidis (Figure by Gro Herredsvela Rørvik).  
   
1.2.2 Persister cells 
Persister cells are cells in a bacterial population that survive treatment with antibiotics by 
other mechanisms than genetic resistance (41). The existence of persister cells have been 
hypothesized ever since World War 2, when the army doctor Joseph Bigger found that 
penicillin failed to completely sterilize staphylococcal infections (42). His work has gained 
new attention the last decades as we have been provided evidence for the existence of 
persister cells and as we in general have become more aware of the limits of antibiotics (43).  
Persister cells are also called phenotypically tolerant cells because they are tolerant to 
antibiotics by mechanisms different from genetic acquired resistance. Persisters and genetic 
antibiotic resistant cells can be separated by the fact that genetically resistant cells are capable 
of growth in the presence of antibiotics, and that persisters do not have an increased MIC 
compared to normal cells (44). Persisters make up a small, phenotypic distinct part of an 
isogenic bacterial population, which survives antibiotic treatment even at very high 
concentrations (45, 46). The reason for their persistence seems to be that they enter a dormant, 
non-dividing state with slow growth and low metabolic activity (47). Since most of our 
Surface material 
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antibiotics targets dividing and metabolic active cells, they fail to target these persister cells 
(23, 48). The persisters can switch from the dormant state to regular growth when the 
antibiotic treatment stops, and thus the infection re-establishes. This new population 
originating from the surviving persisters is just as sensitive to antibiotics as the original 
population, indicating that the tolerance is not heritable (44). This capability to resume regular 
growth after termination of antibiotic treatment makes these infections incredibly difficult to 
treat, and are in many cases thought to be responsible for recurring, chronic infections (46, 
49). A study in Pseudomonas aeruginosa strains isolated from Cystic fibrosis patients showed 
that the later collected isolates contained a 100-fold increase in persisters compared to earlier 
isolates (49). The explanation for this was found to be the formation of high persistent 
mutants, called hip, and that formation of persisters is responsible for the recalcitrance of 
these infections (49). For Cystic Fibrosis patients chronic infections with Pseudomonas 
aeruginosa is often mortal  (50).        
 The occurrence of persister cells has been shown in several distinct bacterial species 
such as Echerichia coli, Salmonella, P. aeruginosa, and also populations of S.epidermidis has 
been shown to include cells with this phenotypic resistance (45, 49, 51, 52). The mechanism 
responsible for making a small part of a large bacterial population tolerant to antibiotics is 
still leading to more questions than answers. Several mechanisms have been proposed, and 
there is a possibility that several different mechanisms may be responsible. The possibility 
also exists that different mechanisms may lead to persistence against different antibiotics as 
indicated in E.coli (51). Stochastic variation, triggering of the SOS response, toxin-antitoxin 
expression patterns and chemical signaling are all mechanisms thought to cause a persistent 
population (53). Until now, only a few studies have been conducted on persister cells in 
S.epidermidis. One study has provided evidence for the existence of persister cells in 
S.epidermidis, showing that treatment with high doses of the antibiotics vancomycin and 
levofloxacin give a small population of 8.21x10
-5 
% and 3.09x10
-7 
% persisters, respectively 
(45). The same study also showed that the number of persisters were highest in stationary 
phase cultures and that biofilm exposed to vancomycin had an astonishing 94% persister 
population (45). As previously mentioned, one of the greatest challenges with bacteria in a 
biofilm is that they are highly tolerant to antibiotics. Another study in P.aeruginosa showed  
that the biofilm gives a protective environment for high levels of persisters, and that the bulk 
of the cells in the biofilm are just as easily eradicated by antibiotics as regular cells when in 
planktonic culture (54). 
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1.3 Antibiotics 
The antibiotic era started in 1928 when Alexander Fleming discovered the bacteriostatic 
effect of penicillin (55). It was used for the first time in the 1940s for treatment of wounded 
soldiers during World War II, and not long after it was made available for civilians (56). The 
discovery of antibiotics was crucial in the treatment of bacterial infections and the mortality 
caused by infectious diseases declined significantly after antibiotics were clinically introduced 
(57). 
1.3.1 Mechanism of action of selected relevant antibiotics 
Antimicrobial compounds target vital cell processes in bacteria, targets that are unique for 
prokaryotes, thereby causing no or limited harm to the host`s own cells. Cell wall synthesis, 
translation, metabolism, transcription or replication are the main targets (48). These processes 
in bacteria involve molecules that are sufficiently different from their eukaryotic homologues 
or not found in eukaryotic cells, like peptidoglycan in the cell wall and enzymes catalyzing 
the biosynthesis of it, and are therefore perfect as antibiotic targets (58). Antibiotics are 
usually classified into classes or families based on their target and chemistry, and we also 
distinguish between bacteriostatic antibiotics which inhibit growth, and bactericidal 
antibiotics that kill the bacteria (59).  The first antibiotics discovered were natural products 
like penicillin from a penicillium mold and streptomycin from the Streptomyces species (55, 
60). Now most antibiotics discovered are synthetic or synthetic derivatives of earlier 
discovered antibiotics (61). 
β-lactam antibiotics 
 Methicillin is a β-lactam antibiotic, belonging to the same class as penicillin and the oldest 
class of antibiotics (62). Methicillin is a semi-synthetic penicillin, and was developed in 1960 
as a treatment to the emerging penicillin-resistant staphylococci (56). The β-lactams exerts 
their effect by inhibiting enzymes in cell wall biosynthesis, subsequently leading to bacterial 
cell death (62). They bind and inactivate important enzymes, for example transpeptidases, 
which are responsible for the final cross-linking of peptidoglycans (62). The β-lactams bind to 
the bacterial cell via proteins collectively called penicillin-binding proteins or PBPs (48, 63).
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Fluoroquinolones 
Levofloxacin is a second generation fluoroquinolone (64). Levofloxacin is a chemically 
synthesized antibiotic that has been approved for use since 1996, and is one of the newer 
antibiotics (64, 65). The fluoroquinolones exert their effect by binding to and inhibiting two 
enzymes involved in replication and transcription (48). These enzymes are unique to 
prokaryotes, the DNA gyrase and DNA topoisomerase IV (66). 
 
DNA gyrase catalyzes the 
formation of negative supercoiling of DNA ahead of the replication fork (64).  Gyrase 
comprises the two A and two B subunits encoded by the genes gyrA and gyrB (64). DNA 
topoisomerase`s main function is to separate the two daughter chromosomes after replication 
(64). DNA topoisomerase is also composed of two C and E subunits, encoded by the genes 
parC and parE. Levofloxacin, like the other fluoroquinolones works by binding to the DNA-
enzyme complex, and thereby halting normal DNA replication and separation of daughter 
strands and eventually leading to cell death (66).       
Glycopeptide antibiotics 
Vancomycin is a glycopeptide antibiotic and like the β-lactam antibiotics it targets 
peptidoglycan biosynthesis and is only used to cure infections caused by gram-positive 
bacteria (67). Vancomycin forms a complex with the peptidoglycan precursor units and 
thereby prevents the peptidoglycan polymerase and transpeptidase from cross-linking the 
peptidoglycan (68). Vancomycin is a natural antibiotic isolated from the bacteria 
Streptomyces orientalis and became available for clinical use in 1958 (68). It quickly became 
an important drug, but because of impure preparations containing fermentation products it 
was also known to be toxic, and was soon replaced by another new drug, methicillin (68). It 
was not until the 1980s that vancomycin got its renaissance because of the appearance of 
methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumonia 
(69). Vancomycin is the primary antibiotic used to cure infections caused by coagulase-
negative staphylococci and is used to treat prosthetic valve endocarditis caused by 
S.epidermidis together with rifampin or an aminoglycide antibiotic (70, 71).  
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Aminocoumarin  
The aminocoumarin class comprises antibiotics produced by different strains of Streptomyces, 
and includes novobiocin, coumermycin and clorobiocin (72). Like the flouroquinolones, the 
aminocoumarin antibiotics target DNA gyrase, but through another mechanism. The 
aminocoumarin antibiotic binds to a domain in the B-subunit having ATP-ase activity, and 
since the formation of negative supercoiling requires energy from ATP hydrolysis, 
aminocoumarin blocks the gyrases ability to induce negative supercoiling on DNA (73). 
Novobiocin is the only aminocoumarin antibiotic approved for use in humans, and is 
primarily used against infections caused by gram positive pathogens (74).  
Oxazolidinones 
Linezolid is a synthetic antibiotic approved for use in 2000 and it is the first oxazolidinone 
antibiotic (75). Linezolid works by targeting bacterial protein synthesis, but efforts to reveal 
the exact mechanism behind this effect has given conflicting results (76).  Early aims to 
determine the mechanism suggested that it worked by inhibiting the initiation phase by 
binding to the 30s or 50s ribosomal subunit, but later studies have shown that it binds to the 
ribosomal peptidyl transferase center on the 50s subunit (76-78). What is more certain is that 
linezolid is not cross-resistant with any other known antibiotics, and that they are very 
effective in targeting gram-positive antibiotic-resistant pathogens like methicillin-resistant 
S.aureus and vancomycin-resistant Enterococcus faecium (76, 79).  
1.3.2 Antibiotic resistance 
Common to all classes of antibiotics is that when they are used, bacteria will at some point 
develop resistance towards them. At some point bacteria have developed resistance against 
every single antibiotic class discovered (57).  Multidrug resistant pathogens are a growing 
health problem world-wide, and for infections by some pathogens, available treatment options 
are few (80). Mutations in the antibiotic target are the most common mechanism for bacterial 
resistance, making the antibiotic unable to bind to the target and thereby also rendering it 
ineffective (58). Active efflux of the drug by the use of pumps and decreased permeability 
over the outer membrane are also mechanisms for drug resistance, especially in gram-negative 
pathogens (81). Resistance in bacteria spread because of the selective pressure antibiotic 
exerts on them. In a bacterial population mutations do occur, and when the population is 
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exposed to antibiotic treatment only the bacterial cells “fortunate” enough to have a mutation 
in the antibiotic target will survive and replicate, as illustrated in Fig 2 (82). Use of antibiotics 
does in other words select for the development of resistance and the indiscriminate 
widespread use of it, for instance in treatment of unserious infections and in agriculture, has 
contributed to speeding up this development (57, 83). 
 
Figure 2: How resistance arises and spread in a bacterial population (Figure by Gro Herredsvela Rørvik). 
 
Already before penicillin was widely used, clinically resistance among some bacteria was 
discovered, and the substance causing it was named penicillinase (63, 84). Today this 
penicillinase is called β-lactamases and is known to catalyse hydrolysis of the β-lactam-ring 
in the β-lactam antibiotics, making them ineffective (62). Methicillin-resistant S.aureus 
(MRSA) and methicillin-resistant coagulase-negative staphylococci are both β-lactam-
resistant and cause major clinical problems (80). The methicillin-resistant staphylococci 
produce a penicillin binding protein called PBP2a encoded by the gene mecA carried on a 
genetic mobile element called the staphylococcal cassette chromosome mec (SCCmec) (80). 
This extra penicillin binding protein does not bind β-lactam antibiotics with the same affinity 
as the other PBPs (58). Data from around 2000 hospitals in the US in 2009-2010 showed that 
43.7% of surgical site infections and 58.7% of catheter-associated urinary tract infections 
caused by S.aureus were caused by methicillin resistant isolates (5). A survey conducted from 
1997-1999 also showed that MRSA isolated from hospitals in Europe was on average co-
resistant to 4.5 other classes of antimicrobials (14). Another way for bacteria to gain 
resistance is through horizontal gene transfer of resistance genes carried on mobile genetic 
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elements. Coagulase-negative staphylococci like S.epidermidis is thought to serve as a 
reservoir for methicillin resistance spreading it to other more virulent staphylococci like 
S.aureus through the horizontal transfer of some subtypes of SCCmec  (85).  Nosocomial 
MRSA increase morbidity and mortality, and with resistance to an increasing number of 
antimicrobials the need for means to control the spread of this pathogen is urgent (86).  
 Vancomycin-resistant enterococci (VRE) with Enterococcus faecalis and 
Enterococcus faecium being the most important species, are other multidrug resistant 
pathogens that are the cause of increasing problems in the nosocomial environment (80). 
These bacteria are known to cause endocarditis, wound and urinary tract infections and 
bacteremia (87). Over a quarter of the E.faecalis genome consists of mobile or acquired DNA, 
which is reflected in their ability to acquire resistance to almost all classes of antibiotics (88). 
Most enterococci species in addition possess intrinsic resistance to most β-lactam antibiotics 
and fluoroquinolones making the challenge of treating these infections even more difficult 
(87). Vancomycin was for a long time the only drug that could be used to eradicate 
enterococcus infections, but in 1988 the first cases of vancomycin-resistance was reported 
(89). Since then vancomycin-resistance in isolates of E.faecium from different health-care 
associated infections has been reported to be present in up to 82.6% of the isolates (5). Today 
the treatment options for infections with VRE are the use of combination of antibiotics from 
different classes and newer bacteriostatic agents like linezolid and tigecyline (80). The 
difficulties in treatment of VRE infections are a good example of the problems that multidrug 
resistant pathogens cause, and the need for new thinking in treatment of this type of 
infections. Bacteria quickly adapt to face new challenges, and overcoming the effects of 
newer antimicrobials will probably not be an exception.       
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1.4 Quorum sensing  
1.4.1 The principles of quorum sensing 
Quorum sensing (QS) is chemical cell-to-cell communication in bacteria that allows them to 
cooperate. They do this through production of signal molecules called autoinducers, whose 
extracellular concentration increases in response to an increasing bacterial population (90). 
According to the Oxford dictionary a quorum is the number of members of an assembly or a 
society that must be present at a meeting to make the proceedings of that meeting valid. This 
is also a good description of this phenomenon in bacteria, which allows bacteria to sense how 
many they are, and make social decision based on cell-population. This allows bacteria to 
coordinate processes that are density- dependent, like bioluminescence, biofilm formation, 
and virulence factors like toxin production (91, 92). These are all processes that are dependent 
on a certain cell density to succeed; it would have little effect if a single bacterial cell started 
to produce toxins in a human host or bioluminescence in a squids light organ. When the 
autoinducers reach a minimum threshold concentration they bind to an extracellular receptor 
which triggers a signal transduction cascade, eventually leading to a change in gene 
expression in the entire population (93). Since the quorum sensing system was first described 
in Vibrio ficheri, a bioluminescent symbiont of the squid Euprymna scolopes light organ in 
the 1970s, the view of bacteria as simple unicellular organisms has changed with an increased 
understanding of their cooperative behavior (94, 95).      
 Several different quorum sensing systems have been characterized, and they are 
usually classified according to the autoinducers and their respective receptors. Some of the 
autoinducers have high intraspecies specificity; others are used for interspecies 
communication (96). The system described in Vibrio fischeri consists of a protein called LuxI 
which synthesizes the freely diffusible autoinducers acyl-homoserine lactone (AHL) and a 
cytoplasmic autoinducer receptor called LuxR, which together control the expression of the 
luciferase operon required for light production (90). Homologues to this LuxIR system are 
also found in many other gram-negative proteobacteria and they each produce AHLs with 
different structure varieties and with specificity for different autoinducer receptors providing 
only intraspecies communication (97, 98). One of the species with LuxIR homologues with 
known function is Pseudomonas aeruginosa, having two LuxIR homologues called LasI-
LasR and RhII-RhiR (99). The target genes that these AHLs regulate differ between species. 
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In P.aeruginosa they have been shown to regulate virulence determinants, production of 
secondary metabolites and structuring of biofilm (98-100).  
 
 
 
     
Figure 3: The basic principle of AHL-based quorum sensing - A small population of bacteria produces a small 
amount of AHLs which diffuse out of the cell. As the population grows, more AHLs are produced. When the 
concentration of AHLs in the environment reaches a certain threshold they bind to the cytoplasmic receptor in 
the bacterial cells, and the gene expression is changed in the population (Figure by Gro Herredsvela Rørvik). 
  
Gram-positive bacteria on the other hand have different systems for quorum sensing, where in 
most cases autoinducer peptides (AIPs) are used as a signal and the receptor is part of a two-
component signaling system (96). The two-component system consists of a membrane located 
receptor histidine kinase and an intracellular response regulator protein that regulates 
transcription of target genes after phosphorylation by the receptor kinase (101).  In contrast to 
AHLs these signaling peptides need to be transported by an ATP-binding cassette exporter for 
the secretion to the extracellular environment (102). This system is found in several different 
gram positive species including Bacillus subtilis and Streptococcus pneumonia, where it 
regulates genetic competence and in S.aureus where it regulates different virulence factors 
(102).  In staphylococcus a two component QS system encoded by the agr locus is found 
(103). The locus comprises of the genes agrA, agrC, agrD, agrB which are co-transcribed, as 
well as a gene for a regulatory RNA called RNAIII with its own promoter (103). The products 
of agrB and agr D combines to generate the signaling peptide which is 7-9 amino acids long 
and contains a thiolactone ring (104). This peptide binds to the transmembrane histidine 
kinase receptor encoded by agr C, which autophosphorylates itself before phosphorylating the 
product of agrA, the response regulator. agrA activates its own promoter and the promoter for 
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RNAIII, and thereby increases expression of the agr locus and RNAIII, which controls and 
up-regulates several genes (103). In S.epidermidis it has been shown that agr negatively 
regulates the production of the autolysin AtlE, involved in attachment to polystyrene surfaces, 
and that agr negative mutants had a greater capacity to adhere to the surface  and thereby also 
increased biofilm formation (92). Even though the agr system is found in most Staphylococci 
differences in the AIPs and the cognate receptors leads to species specificity (103).  
 A more universal Quorum sensing system based on the autoinducer AI-2 is found in a 
number of different species. It is found in both gram-positive and gram-negative bacteria, and 
is thought to be used for interspecies communication (90). The autoinducer AI-2 is 
synthesized by the product of the LuxS gene, with homologues found in over 500 sequenced 
bacterial genomes (105). LuxS is the third enzyme in the S-adenosylmethionine (SAM) 
utilization pathway, in which SAM is utilized as a methyl donor in cellular processes, and is 
required to convert SAM to homocysteine and 4,5-dihydroxy-2,3-pentanedione (DPD) (Fig.4) 
(106).  DPD is not thought to be the signaling molecule but an AI-2 precursor, because it is 
highly reactive and unstable in solution, and therefore cyclizes into a furanone ring that is 
thought to be AI-2 signaling molecule (106). The structure of AI-2 has only been solved for 
two species, V.harveyi and Salmonella typhimurium (Fig.4) (107).  
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Figure 4: The activated S-adenosylmethionine cycle (SAM) and the structure of DPD and known AI-2 
molecules. DPD is made as a by-product in the SAM-cycle when S-ribosyl-homocysteine (SRH) is converted to 
DPD and homocysteine by the LuxS synthase enzyme. The AI-2 precursor DPD can spontaneously cyclize into 
different AI-2 signaling molecules, as seen in V.harveyi or in S.typhimurium. Based on figure by Sun, J, et al 
(Figure by Anne Aamdal Scheie) (108).  
The AI-2 based quorum sensing system was first discovered in V.harveyi. It was found that 
AHL-mutants unable to communicate through this AHL pathway were still capable of 
quorum sensing and were still producing bioluminescence in response to cell density (109).  It 
was also found that these AHL- negative mutants responded to cell free supernatants from 
both marine and terrestrial bacterial species like Yersinia enterocolitica and Vibrio cholerae 
through AI-2 quorum sensing, leading to the conclusion that this could be an interspecies 
communication system (110). An interspecies communication system would give the bacteria 
the advantage to monitor the number of non-self-cells in the environment and coordinate 
behavior in response to it, in addition to the intraspecies QS systems allowing them to monitor 
the density of own cells (96). S.epidermidis is one of the species having this luxS homologue 
and is capable of AI-2 quorum sensing (Fig.5) (111). In S.epidermidis it has been shown that 
the luxS gene is involved in negative inhibition of PIA-production and that a luxS mutant 
therefore produces thicker biofilms and has an increased capacity to cause CVC-associated 
infections in a rat model (112) . But a study carried out with another clinical isolated strain of 
26 
 
S.epidermidis has shown that inhibiting AI-2 mediated communication leads to decreased 
biofilm formation, giving some conflicting results of the role of luxS in biofilm formation 
(113). AI-2 has also been shown to regulate genes involved in metabolism, virulence 
associated genes coding for lipases and the production of phenol soluble modulins (PSM) 
which are virulence factor that triggers cytokine release in cells of the human innate immune 
system potentially leading to sepsis (114, 115). 
 
Figure 5: S.epidermidis RP62A luxS gene sequence (111).  
1.5 Quorum sensing inhibition 
Since quorum sensing regulates several virulence factors crucial for bacterial pathogenesis, 
like toxin production and biofilm formation, interfering with or quenching this 
communication could potentially lead to a new way to treat or control bacterial infections. 
The process of autoinducer biosynthesis, autoinducer accumulation and receptor-ligand 
recognition involves several molecules unique to bacteria that could serve as novel targets for 
a new class of antimicrobial drugs. In contrast to most of the antibiotics now in use, inhibiting 
quorum sensing would not directly affect fitness and thereby not conduct any selective 
pressure on the bacteria, and will therefore not contribute to select for drug resistant 
pathogens (116). Seen especially interesting, is inhibition of quorum sensing through AI-2, 
because this could lead to the development of broad spectrum therapies targeting both gram 
positive and gram negative pathogens (96). Quorum sensing inhibiting drugs could be used in 
combination with antibiotics, for instance in the treatment of bacteria where biofilm is a key 
virulence factor, hindering biofilm formation that makes the bacteria far more antibiotic 
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tolerant. This could possibly make the treatment of chronic infections involving pathogens 
with biofilm formation as a key pathogenicity property far more successful than it is today.  
1.5.1 Furanones  
Halogenated furanones were first isolated as  secondary metabolites from the macro alga 
Delisea pulchra after it had been observed that this alga was somehow able to avoid bacterial 
surface colonization (117). The reason that D.pulchra did not have the widespread surface 
colonization seen on other alga was found to be that these halogenated furanones had 
structures resembling AHL-signaling molecules and therefore disrupted QS-signaling in 
bacteria (118). They were shown to be antagonistic inhibitors of AHL-mediated signaling 
through interference with the luxR receptor without affecting growth of the bacteria (119). 
These compounds was shown to inhibit several pathogenicity associated bacterial processes 
known to be quorum sensing-dependent, like the AHL-dependent swarming motility in 
Serratia liquefaciens and bioluminescence and toxin production in V.harveyi (120, 121). It 
was later demonstrated with the use of a V.harveyi QS reporter strains that one of these 
natural brominated furanones from Delisea pulchra not only inhibited quorum sensing 
through interference with AHL-mediated signaling, but that it also did so independently 
through AI-2 interference (122).          
 With these natural furanones as a starting point several synthetic furanone analogues 
with the ability to inhibit quorum sensing has been synthesized and many possible 
applications have been  examined  (123). It has been shown that biofilms grown in the 
presence of a synthetic furanone are more susceptible to antibiotics and that the furanone 
contribute to a more rapid clearance of P.aeruginosa infection in a mouse model (124). In 
S.epidermidis it has been shown that coating surface materials with furanones at a non-
antimicrobial concentration decreases biofilm formation, showing that furanones could have a 
potential in avoiding implant associated biofilm infections (125, 126). Furanones has also 
been shown to reduce persister cell formation during growth and sensitizing the persisters to 
antibiotics in both E.coli and P.aeruginosa (127, 128). Together all of these results on 
furanones ability to control bacterial behavior associated with pathogenicity implicates that 
quorum quenching could have a promising future in the search for new therapies against 
bacterial infections.  
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1.5.2 Tiophenones 
Thiophenones are analogues of furanones where the oxygen atom of the furanone is replaced 
by a sulfur atom, and like the furanones they are also able to inhibit biofilm formation (129). 
Several studies have compared the effect of furanones and thiophenones on different 
virulence traits thought to be quorum sensing dependent. A thiophenone, TF101, structurally 
related to a furanone has been shown to inhibit biofilm formation in S.epidermidis more 
effectively than the furanone, whereas a structurally different thiophenone, TF310, has been 
shown to be the most effective one (113). In the same study it was also demonstrated that both 
the thiophenones and the furanone were able to inhibit bioluminescence in a V.harveyi AI-2 
reporter strain, the thiophenones being more effective than the furanone. This indicates that 
thiophenones are QS-inhibitors inhibiting AI-2 mediated signaling, even more effectively 
than furanones. A study on thiophenones ability to protect brine shrimp larvae from V.harveyi 
infection has demonstrated that the thiophenone, TF310, at concentration of only 2.5μM could 
completely protect the larvae from infection, without being toxic (130). A previous study 
showed that to achieve the same protection of the larvae from V.harveyi, a concentration of 
65μM of a synthetic furanone was needed (130, 131).  The exact mechanism of action of the 
quorum sensing inhibition of thiophenones is still not completely understood. Experiments 
where E.coli have been pre-treated with thiophenones have given some insight, as it was 
shown that this pre-treatment not affected the ability of the supernatant to induce 
bioluminescence in a V.harveyi reporter strain, indicating that thiophenones does not affect 
AI-2 synthesis, but rather has an effect at receptor-level (132). Many thiophenones with 
different substituents have been synthesized, and several of them have been shown to have 
biofilm inhibiting properties (133). Studies on these different thiophenones could reveal more 
of the potential that QS-inhibitors could have in infection control. So far, thiophenones have 
been shown to inhibit quorum sensing in both gram negative and gram positive bacteria and 
in having an effect on various virulence traits thought to be quorum sensing dependent, 
without being toxic.   
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2 Aims of the study 
The main goal of this work is to study the effect of AI-2 quorum sensing inhibition using 
different thiophenones on various important virulence factors in the opportunistic pathogen 
S.epidermidis. 
Sub goals: 
 To study the ability of selected thiophenones to inhibit AI-2 based quorum sensing by 
using a bioluminescence assay.  
 To study the effect of thiophenones alone and in combination with selected antibiotics 
on the formation of biofilm by S.epidermidis.  
 To establish a method to isolate S.epidermidis persister cells and test whether 
thiophenones could revert the cells to antibiotic tolerance. 
 To study the ability of thiophenone to affect S.epidermidis adherence to eukaryotic 
cells.  
 To establish an infection model in C.elegans. 
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3 Materials and methods 
3.1 Materials 
Bacterial strains 
All bacterial cultures were stored in appropriate culture media supplemented with 30% 
glycerol in a -80°C freezer. When needed, one of the bacteria stocks was thawed and 
inoculated in appropriate culture media. The rest of the stock was discarded to avoid repeated 
thawing and freezing. 
Table 1: Bacterial strains used in this study 
 
 
 
 
 
 
 
Thiophenones 
Thiophenones were stored in absolute ethanol to a concentration of 100mM in a -20°C 
freezer. This stock was further diluted in tryptic soy broth (TSB) (BD Bacto™) to a working 
solution, and stored in a -20°C freezer. When needed the thiophenone working stock was 
thawed, and any remaining solution was discarded to avoid thawing and freezing.  
Antibiotics 
All antibiotic stocks were prepared from powder and a suitable solvent. Levofloxacin 
(SIGMA Life science) was diluted in 70% ethanol and novobiocin (SIGMA Life science), 
Strains designations/ATCC number Genus 
RP62A/ ATCC 35984 S.epidermidis   
AMC 263/ ATCC 155 S.epidermidis  
HFH-30172 / ATCC 1694 S.aureus   
MM32/ BAA-1121 V.harveyi  
OP50 E.coli 
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linezolid (SIGMA Life science) and vancomycin (Aldrich chemistry) was diluted in d
2
H20 
and stored in a -20°C freezer. It was thawed and further diluted to a working concentration in 
TSB when needed. Any remaining solution was discarded. 
Statistics 
All statistical analyses were performed using Sigmaplot 12.5.  
3.2 MIC determination 
S.epidermidis RP62A was grown by inoculating 10µl of frozen stock in 10ml TSB (tryptic 
soy broth) and grown to OD600nm 0.1 at 37°C with shaking at 180rpm, approximately 4.5 h. 
S.epidermidis together with different antibiotic concentrations was added in a 96-well 
microtiter plate (Nunc). The antibiotic concentrations chosen were both below and above 
MIC values found in literature. Dilutions with 0,625 times difference between each well was 
achieved by adding the selected antibiotic in TSB to a total volume of 200μl in well number 1 
and 75μl TSB in the other wells, and then adding 125μl from well 1 to well number 2, mixing, 
and then moving 125μl from well number 2 to well number 3 and so on. 75μl S.epidermidis 
culture was then added to all wells except sterile control with only TSB to a final volume of 
150μl in each well. Since each well with antibiotic was diluted one time when the culture was 
added, the antibiotic concentration in the wells was twice of wanted final concentration. The 
plates were incubated at 37°C without shaking overnight (16-18 h). OD600 nm was measured in 
a plate reader (Synergy HT, BIO-TEK
®
).  
3.3 Thiophenones as AI-2 signaling inhibitors 
Vibrio harveyi MM32 was grown in HI media (BD Bacto™) supplemented with 20g NaCl\L 
at 30°C with shaking 180rpm overnight, then 10% of the culture was transferred to BA-media 
(recipe in supplementary) and grown for second overnight. S.epidermidis RP62A supernatant 
was prepared by inoculating 5µl frozen culture in 5ml TSB, HI or BHI (BD Difco™), and 
incubating it for 4 h, 6 h or 16 h, at 37°C with 180rpm shaking. This was followed by 
centrifugation at 8000g in 10 min, and filter sterilization of the supernatant with a 0,2μm 
celluloseacetate filter (Whatman
®
) to a cell free supernatant. The assay was done by 
incubating V.harveyi MM32 together with 2.5μM of the AI-2 precursor DPD or S.epidermidis 
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supernatant in a 96-well plate (Nunclon™ DELTA Surface, Nunc™) to a total volume of 
100μl, 4 replicas of each. The plate was incubated at 30°C with 350rpm shaking for 3 h 
(Eppendorf Thermomixer comfort), and luminescence was measured using a plate reader 
(Synergy HT, BIO-TEK
®
). Next, AI-2 signaling inhibitors TF101, TF301, TF310 or TF403 
were added to a final concentration of 2.5μM, concentration was chosen by comparing the 
effect of 2.5μM and 5μM in an independent experiment. The bioluminescence was measured 
directly after application of thiophenones, the plate was then incubated at 30°C with shaking 
350rpm, and the luminescence was measured every 30 min for one and a half hour. The 
protocol was repeated in at least two independent experiments. 
 
 
                
Figure 6: Structure of the thiophenones used in the experiments, TF101, TF301, TF310 and TF403. 
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3.4 The effect of thiophenones and antibiotic on 
biofilm formation 
To test the effect of thiophenone and thiophenone in combination with antibiotics on biofilm 
formation, aliquots of 5µl S.epidermidis RP62A was inoculated in 5ml TSB overnight, and 
diluted to OD600nm=0.1.  Dilutions of thiophenones to a final concentration of 10µM and 
selected concentrations of antibiotic were made in 15ml falcon tubes, and culture was added 
to a final OD600nm= 0,05. Samples of 400µl were transferred to 48-well plates (Multiwell™ 
BD Falcon™), 2-4 replicas of each sample. Samples of TSB and S.epidermidis culture were 
used as sterile/blank and growth control, respectively. The plates were incubated at 37˚C with 
no shaking and biofilm was allowed to form for 6 h. This was found to be the optimal time for 
biofilm formation in a preliminary experiment; a lot of biofilm was forming without the 
biofilm starting to detach (results not shown). After 6 h the plates were read at OD600nm in a 
plate reader (Synergy HT, BIO-TEK
®
), to see if the thiophenone and the antibiotic affected 
growth of the bacteria. To quantify the biofilm, safranine staining was used (134). The 
supernatant was discarded, and the biofilm was washed twice in 0.9% NaCl to remove any 
unbound cells. The biofilm was stained with 200µl 0.1% safranine for 30 min, and then the 
biofilm was washed in 0.9% NaCl until all excess color was removed. The plates were 
allowed to dry, and 200µl 30% acetic acid was added to release bound dye. The amount of 
biofilm was measured by reading the plates at OD530nm in a plate reader (Synergy HT, 
BIOTEK
®
). 
.  
Figure 7: Safranine stained biofilm (Gro Herredsvela Rørvik). 
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3.5 Persister isolation 
To decide the best time to isolate persister cells, and the optimal antibiotic concentration for 
it, S.epidermidis RP62A persister cells was isolated from planktonic culture as described by 
Shapiro et al, with slight modifications (45). Briefly, an overnight culture was diluted 1:1000 
in TSB to an OD600nm of approximately 0.01 and incubated at 37°C with shaking 180rpm. 
Every other hour two samples were removed from the culture. One sample got 25μg/ml or 
50μg/ml of levofloxacin added, and was incubated for another 24 h, until all non-persister 
cells presumably were killed. The other sample was diluted in a 96-well plate and 6 replicas 
of 10μl were plated on tryptic soy agar (TSA), by using the drop plate method for colony 
counting described by Chen et al. to determine the original CFU/ml in the sample before 
antibiotic treatment (Fig.8) (135). After 24 h the antibiotic treated samples were washed twice 
by centrifugation at 14000g for 2 min, removing the supernatant and re-suspending the pellet 
in TSB. The sample was then diluted and plated out in the same way as described above.  
After colony counting one colony from two different time points were selected for MIC-
testing, to assure that the isolated cells were persisters and not had developed resistance. The 
MIC testing was done as described above. 
                            
Figure 8: Drop plate method for colony counting (Gro Herredsvela Rørvik). 
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Optimal time for isolation of persisters was decided to be after 2 h and 6 h of growth, to 
compare the amount of persisters in lag phase culture with exponential phase culture, and 
these time points for isolation was used in further experiments. Persisters were isolated in 
three independent experiments with 50μg/ml levofloxacin as described above, but with 
samples only taken from the culture after 2 h and 6 h of growth (Fig.9).    
            
Figure 9: Flow chart showing the protocol used for persister isolation (Figure by Gro Herredsvela Rørvik).
    
3.5.1 The effect of thiophenones on persister formation 
Persisters were isolated after 2 h and 6 h as described above. The effect of 5μM thiophenone 
was tested in two ways to try to establish the best method for testing their effect on persister 
formation. It was tested as a pre-treatment added to the culture after dilution to OD600nm = 0.05 
before incubation in 2 h or 6 h, and were not removed by washing before levofloxacin was 
added, and in combination with antibiotic added at the same time as levofloxacin. Persisters 
isolated without any form of thiophenone treatment were used as a control and untreated/pre-
treated culture was used to calculate original CFU/ml. All experiments were repeated twice. 
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3.6 The effect of thiophenones on adhesion to 
eukaryotic cells 
CaCo-2 cells were grown to a confluent layer in a 12-well plate, approximately 300 000- 
500 000 cells/well. The number of bacteria in a S.epidermidis RP62A overnight culture was 
decided by diluting it to OD600nm=0.5, and counting the number of bacteria in a counting 
chamber (PETROFF-HAUSSER), and calculating CFU/ml. S.epidermidis was diluted in cell 
medium so that there would be approximately 40 bacteria per cell in each well. TF101, TF310 
or TF403 were added to the wells in duplicate to a final concentration of 5µM, and 
S.epidermidis without thiophenones was used as a control. The plates were centrifuged in 5 
min 600rpm so that the bacteria would go down to the cell layer. The plates were incubated at 
37°C in 90 min. The wells were then washed three times in phosphate-buffered saline (PBS) 
to remove any non-adherent bacteria. Next, 1ml dH2O was added for lysing of the cells and 
plates were incubated at 37°C in 15 min.  The cells were then scraped with the help of a 
pipette tip, followed by incubation for another 15 min, at 37°C. The lysates were then 
collected in eppendorf tubes, and diluted from 10
-1
to 10
-4 
in PBS. Duplicates of 25µl from 
each sample were then plated out on tryptic soy agar, and were incubated at 37°C overnight 
before colony counting and calculations of the number of adherent bacteria to each cell.  
3.7 Establishment of an infection model in 
Caenorhabditis elegans 
Caenorhabditis elegans were grown on plates with nematode growth agar (NGM) (recipe in 
supplementary) containing an E.coli:OP50 lawn as food source at 15°C for 5-6 days to get 
adults that carried eggs. The worms were washed off the plates with M9-buffer (recipe in 
supplementary) and the worms were collected by adding the buffer to a 15ml conical tube and 
centrifuged for 1 min at 1000g. The supernatant was removed and the worms were lysed with 
freshly made bleach solution prepared immediately before use (3ml hypochlorite solution 
O.1M, 3.75ml NaOH 1M and 8.25ml d
2
H2O). The tubes were gently shaken by hand during 
the lysis of the worms, approximately 3 min. It was important that the lysing process did not 
exceed 5 min, because this could lead to destruction of the eggs. The tubes were then 
centrifuged at 1000g for 1 min and the pellet was re-suspended in 5ml M9 buffer. This 
washing step was repeated three times before the supernatant were re-suspended in 5ml M9-
buffer and the eggs were incubated in room temperature overnight with gentle shaking on a 
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2D rotator for the eggs to hatch. The day after the L1 worms hatched from the eggs, and was 
harvested. They were allowed to swim down to the bottom of the tube, and most of the M9-
buffer was removed. The small larvae were transferred to petri plates with NGM-agar with a 
lawn of E.coli:OP50. They were incubated for 48 h at 25°C to get L4 larvae’s that were going 
to be used in the infection experiment.        
 To study infection of C.elegans by different bacterial strains, S.epidermidis RP62A, 
S.epidermidis ATCC 155 and S.aureus ATCC 1694 were grown by transferring a single 
colony to 3ml brain heart infusion(BHI) and incubating for 2 h at 37°C with 180rpm shaking, 
and dilute it to a OD600nm= 0.1. To prepare infection plates 5µl of each strain were smeared on 
6-well plates containing BHI20-NGM-agar (recipe in supplementary), 6 replicas of each. A 
control sample, a 6-well plate with E.coli:OP50 was prepared in the same way. This was used 
as a control because it is known that this strain is not pathogenic to the worms. The 
E.coli:OP50 plates were incubated overnight in room temperature and the others were 
incubated at 37°C overnight.         
 The L4 or young adult hermaphrodite worms that had been incubated for 48 h, were 
washed off the plates with M9-buffer, and collected in 15ml falcon tubes. They were washed 
three times by centrifuging for 1 min at 600g, removing the supernatant and then adding new 
M9-buffer. The washing step was repeated three times to remove all E.coli:OP50. Worms per 
10µl were counted in a dissecting microscope (Leica MZFLIII), to determine the appropriate 
volume to add to each well. Between 15 and 25 worms were transferred to the lawn of the 
different bacteria to be tested and to control sample. Worms were allowed to spread on the 
wells for approximately two hours, and then the worms were counted and dead worms 
registered. The plates with the worms were incubated at 25°C and worms were counted in a 
microscope with 24 h interval for seven days in the microscope, to determine how many 
dead\alive worms there were in each sample. Dead worms were registered as worms which 
had lost their sinusoidal form, were no longer moving, and in some cases had become 
transparent with only the outline of the worm showing or they had a rupture in the vulva area 
(Fig.10). The results of the control plates were compared with the ones with the two 
S.epidermidis strains and the one with S.aureus, to determine if any of the strains were 
pathogenic to C.elegans. 
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Figure 10: Separating live and dead C.elegans. Live, sinusoidal shaped C.elegans A) and B), dead, flattened 
C.elegans in C) and dead C.elegans with rupture in the vulva area D) (Micrograph - Leica MZFLIII). 
 
3.7.1 The effect of thiophenones on C.elegans recovery after 
infection 
Worms and infection plates were prepared in the same way as described above. Three control 
plates with 6 parallels of E.coli:OP50 were prepared and four plates with 6 parallels of 
S.aureus were prepared and used for infection. Approximately 50 L4 worms were transferred 
to each of the wells. After 24 h of infection, all worms were washed of the wells with 2ml 
M9-buffer, and collected in two falcon tubes. The worms were washed three times by 
centrifugation at 600g for 1 min, and re-suspending in 10ml M9-buffer. After washing most 
of the M9-buffer was removed and worms per 10µl were counted.    
 Recovery of the worms was tested in liquid media in a 48-well plate. 2.5P-media 
(recipe in supplementary) was used to test the recovery of the worms infected by S.aureus, 
and BHI-M9-media was used to test recovery/survival of the worms grown on E.coli:OP50.  
The effect of thiophenones on recovery was tested by adding 5µM TF310 to 2.5P media and 
as a toxicity control E.coli:OP50 grown worms were added to BHI-M9 media containing 5µM 
TF310. d
2
H2O was applied to the edges of the plate to avoid plate drying. One row remained 
empty due to a low number of worms, because of loss of worms between each step. 
Approximately 10-20 worms from the two different samples were transferred to the wells. 
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Dead worms were registered in a dissecting microscope (Leica MZFLIII), and the plate was 
incubated in a 2D rotator in room temperature. Live\dead worms were registered every 24 h.  
 
Table 2: Plate layout for C.elegans recovery experiment.  
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4 Results 
4.1 MIC determination 
The minimal inhibitory concentration (MIC) is the lowest concentration of an antimicrobial 
compound that will completely inhibit growth of a microorganism (136). MIC values for 
levofloxacin, novobiocin, linezolid and vancomycin were assayed for S.epidermidis RP62A. 
When deciding which concentrations to test, values found in the literature was used as a 
starting point and concentrations both below and above were tested. This was done because 
MIC values can vary between different test conditions, like growth media and size of 
inoculum, and MIC-values found in the literature could not be expected to be the same as 
under these experimental conditions.  
 
Figure 11: MIC-testing for levofloxacin A), linezolid B), novobiocin C) and vancomycin D).Result represented 
as mean of at least two independent experiments. 
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Results in Fig.11 show the mean results for all replicas from two or four experiments, with 
error bars representing standard error. For vancomycin, linezolid and novobiocin the 
experiments were repeated twice with three parallels each time. For levofloxacin the 
experiment was repeated four times with three parallels each time, because there were no 
clear results from the first two experiments. Under two of the experiments the concentration 
that inhibited growth was 0.095µg/ml and under the two other experiments it was found to be 
0.059µg/ml. The MIC was decided to be in between these two values, around the mean which 
is 0.077µg/ml. For novobiocin, vancomycin and linezolid the MIC values were 0.19µg/ml, 
5.075µg/ml and 1.9µg/ml, respectively. In Fig.11B) and C) it may seem like the MIC-values  
were not completely inhibiting growth, but this is probably due to the fact that the optical 
density of the inoculum before incubation were not measured and subtracted from the results.   
4.2 Thiophenones as signaling inhibitors 
V.harveyi MM32, a non-bioluminescence producing AI-2 reporter strain having the AI-2 
receptor, was used to study the effect of thiophenones as communication inhibitor. 
Bioluminescence was induced in V.harveyi MM32 by 2.5µM DPD, and repressed by addition 
of 2.5µM or 5µM of the different thiophenones. All thiophenones tested inhibited 
bioluminescence compared to the control, at both concentrations. The results (Fig.12) shows 
that TF101 was the most effective, inhibiting bioluminescence at both 2.5µM and 5µM, with 
98.4% and 99.5% respectively. Even the least effective thiophenone, TF310 at 2.5µM, 
inhibited bioluminescence as much as 83% compared to control. The results from this 
experiment showed that the most effective thiophenones at a concentration as low as 2.5µM 
was sufficient to almost completely inhibit AI-2 signaling. All samples were significantly 
different from control (p<0.05, paired t-test). Results are mean of three replicas in one 
experiment.  
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Figure 12: Effect of different thiophenones on bioluminescence in V.harveyi MM32at 2.5µM A) and 5µM B). 
 
It was also attempted to induce bioluminescence in V.harveyi MM32 with sterile 
S.epidermidis RP62A supernatant. Fig.13 shows the results after trying to induce 
bioluminescence with a supernatant prepared after 4 h growth in both HI and BHI. Results are 
mean of four parallels with four replicas of each. There were no bioluminescence detected, 
compared to control where bioluminescence was induced by DPD.  
 
Figure 13: Bioluminescence in V.harveyi MM32 after induction by DPD and S.epidermidis supernatant prepared 
both from BHI and HI.  V.harveyi MM32 with BA-media were used as negative control.  
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4.3 Thiophenones and antibiotic as inhibitors of 
biofilm formation 
The effect of four different thiophenones at 10µM in combination with three different 
levofloxacin concentrations on biofilm formation in S.epidermidis RP62A is shown in Fig.14. 
The results show the mean of two individual experiments with 2-4 replicas of each sample, 
with error bars representing standard error. TF310 was the only thiophenone that made the 
antibiotic more effective in inhibiting biofilm formation, at all three tested concentrations. 
However, none of these results were statistically significant (one way ANOVA) (Fig.14C). 
TF403 increased biofilm formation compared to control (p=0,009, one way ANOVA). TF403 
in combination with 0.15µg/ml levofloxacin inhibited biofilm slightly more effectively than 
the same concentration of levofloxacin alone, but this result was not statistically significant 
(one way ANOVA) (Fig.14D). TF101 in combination with 0,08µg/ml antibiotic (Fig.14A), 
seemed to inhibit biofilm formation more effectively than with antibiotic alone, but this 
difference was also not statistically significant (one way ANOVA). 
 
Figure 14: Effect of thiophenones TF101 A),TF301 B),TF310 C) or TF403 D) in combination with  
levofloxacin in inhibiting biofilm formation. Results are represented as mean of two independet experiments. 
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4.4 Persister isolation 
To find optimal time for persister isolation and to make sure that antibiotic concentrations 
chosen were high enough to eradicate all non-persister cells, experiments were carried out 
where persisters were isolated every other hour of growth during 10 h. They were supplied 
with either 25µg/ml or 50 µg/ml levofloxacin (almost 325x and 650x MIC). The experiments 
were carried out once for each treatment, and with only one sample. Numbers of persisters 
were calculated as the percentage of original culture that survived the antibiotic treatment. 
The results from the first 4 h of growth are compared in Fig.15. The results show that from 0 
h-2 h of growth, the number of persisters isolated was higher when the sample was treated 
with 50µg\ml than when it was treated with 25µg/ml. After 4 h the number of persisters in the 
two samples was more similar, 3.76x10
-6 
% for 50µg/ml and 4.67x10
-6 
% for 25µg/ml.  
 
Figure 15: Comparing the percentage of persisters isolated at different time points during growth with either 
25µg\ml levofloxacin or 50µg\ml levofloxacin. 
MIC testing was done on two of the plates containing persisters, to assure that survival was 
not due to development of resistance against levofloxacin. Results are shown in Fig.16. 
Results of MIC-testing of persister isolated after 8 h of growth showed that the MIC was in 
between 0,095µg/ml and 0,152µg/ml (A). MIC-testing carried out on persisters isolated after 
10 h of growth obtained a MIC-value close to 0,152µg\ml (B). The MIC-value for the isolated 
persister was higher than for the untreated culture, where MIC was found to be around 
0.077µg\ml, but not high enough to be caused by resistance.  
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Figure 16: Shows the result on MIC-testing carried out on persisters isolated after 8 h(A) and after 10 h of 
growth(B).  
 
Based on the results of the previous experiments, isolation of persisters in the following 
experiments was performed after 2 h and 6 h of growth, and by addition of 50µg/ml 
levofloxacin for 24 h. This was done in three independent experiments. Persisters were 
calculated as the mean percentage that survived levofloxacin treatment of the original CFU/ml 
in the culture before levofloxacin was added. Results are shown in Fig.17. At most, 4.6x10
6 
CFU/ml of S.epidermidis RP62A survived levofloxacin treatment, out of a culture of 
originally 6.5x10
9 
CFU/ml.  
 
Figure 17: The percentage of S.epidermidis RP62A cells that survived 24 h  treatment with high concentrations 
of levofloxacin , added at 2 h and 6 h of growth. 
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4.4.1 Effect of thiophenone treatment 
The effect of thiophenone TF310, TF101 and TF403 on persister development and persister 
sensitivity to antibiotics were investigated. First, the effect of TF310 on persister development 
during growth was assayed, by adding TF310 to the culture prior to antibiotic treatment for 24 
h. Results from two independent experiments are shown in Fig.18. In Fig.18A and C CFU/ml 
in the samples pre-treated with TF310 and the samples without any pre-treatment are 
compared. In all samples except one, 6 h of growth shown in C, the addition of 5µM TF310 
did not affect growth of S.epidermidis RP62A negatively. In Fig.18B and D, the percentage of 
the original culture that survived levofloxacin treatment, the persisters, are shown. In the first 
experiment (Fig.18A and B), there was a higher percentage of persisters in the culture pre-
treated with TF310 for 2 h, but not for the culture pre-treated for 6 h. In the second 
experiment, (Fig.18C and D), the results were opposite. For 2 h the number of persisters was 
almost the same, with 0 persisters isolated from the untreated sample and 33 CFU/ml 
persisters in the pre-treated sample. After 6 h the percentage of persisters isolated from the 
pre-treated culture were higher than for the untreated culture.   
 
Figure 18: The amount of cells in samples grown with or without 5µM TF310 for 2 or 6 h (A,C). The 
percentage of cells in each of  the samples that survived 24 h treatment with levofloxacin (B,D). A and B 
together, and C and D together represent one independent experiment 
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The effect of TF403 was tested in the same way as for TF310, as a pre-treatment added to the 
culture 2 h or 6 h before levofloxacin was added. Two independent experiments were 
performed. Result from the first experiment is shown in Fig.19. Original cell number in the 
samples grown with or without TF403 is shown in Fig.19A. TF403 at 5µM did not affect 
growth negatively after 2 h of growth, but seemed to have a positive effect on growth. After 6 
h CFU/ml had equalized in the two samples, and the sample without TF403 had grown more 
than the one with TF403 added. CFU/ml surviving levofloxacin treatment is shown in B, and 
it showed that the amount of cells that survived the levofloxacin treatment was quite high, 
over 1x10
6
 when isolated after 6 h growth. It also shows that the number of cells that survived 
the treatment is quite stable, regardless of the amount of cells originally in the culture. The 
percentage of the different samples that survived the treatment is shown in C). After 2 h there 
was fewer surviving persisters in the sample pre-treated with TF403, but after 6 h it had 
changed and the sample pre-treated had higher percentage persisters.    
 
 
Figure 19: The effect of TF403 as a pre-treament on persister developement/survival compared to an untreated 
culture. Original CFU/ ml in each culture after 2 h and 6 h of growth A), the amount of isolated persisters B) and 
the percentage of the original cultures surviving 24 h levofloxacin treatment are shown in C). 
Result from a second experiment with TF403 carried out in the same way is shown in Fig.20. 
Also in this experiment the sample with TF403 added had slightly more growth after 2 h, but 
after 6 h the untreated sample had the highest CFU/ml (Fig.20A). The number of surviving 
persisters after 2 h was lower than for the first experiments, but after 6 h the number were 
quite stable at 1x10
6 
CFU/ml (B). At both time points the untreated sample had more 
persisters in CFU/ml, despite the fact that the pre-treated sample had a higher CFU/ml after 2 
h of growth. This is also reflected when looking at the percentage of original culture surviving 
levofloxacin treatment (C), as it was more persisters isolated from the untreated sample than 
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from the TF403 treated sample. After 6 h there were a total of 0,043% persisters isolated from 
the pre-treated culture and 0,054% from the untreated culture.  
 
 
Figure 20: The effect of TF403 as a pre-treament on persister developement/survival compared to an untreated 
culture. Original CFU/ml in each culture after 2 h and 6 h of growth A), the amount of isolated persisters B) and 
the percentage of the original cultures surviving 24 h levofloxacin treatment are shown in C). 
 
The effect of TF101 was tested by adding it to the culture at the same time as levofloxacin. 
This was done in two independent experiments. The results of these two experiments are 
shown in Fig.21, were graph A and B represents one experiment, and graph C and D the 
second experiment. In Fig.21A, CFU/ml before removing samples and adding levofloxacin or 
levofloxacin in combination with TF101 are compared with the number of persisters 
surviving the different treatments. After both time points the amount of persisters isolated 
from the culture treated with TF101 in combination with levofloxacin were higher. When 
looking at the percentage of the original culture surviving the treatment (B), the sample 
treated with TF101 had the highest percentage of persisters (3x10
-4 
% compared to 0% after 2 
h, and 0,1% compared to 0,011% after 6 h).       
 The second experiment was carried out slightly differently, instead of removing 
samples from one culture, counting CFU/ml and adding levofloxacin with or without TF101, 
two different cultures were grown where samples from one got TF101+levofloxacin added, 
and samples from the other got only levofloxacin added. Accordingly, the original CFU/ml 
before levofloxacin treatment and TF101 addition is shown in C. There was no major 
difference in CFU/ml in the two cultures before the treatment. The percentages surviving the 
different treatments are shown in D. Also in this experiment there were a higher percentage of 
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surviving persisters in the culture treated with TF101 compared to the untreated culture, but 
the difference was not as clear as in the first experiment.  
 
 
Figure 21: Results from two experiments testing the effect of TF101 on persister survival, A) and B) represent 
the first experiment, C) and D) the second.  
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4.5 Adhesion to eukaryotic cells 
To look at the effect of three different thiophenones on bacterial adherence to eukaryotic cells, 
two experiments were carried out with S.epidermidis RP62A and Caco-2 cells, with two 
parallels each time. In the first experiment (Fig.22A) the addition of thiophenones led to more 
bacteria adhering to the cells. In the second experiment (Fig.22B), there were no clear 
difference between the cells treated with 5µM thiophenones and the control. Results are 
presented as CFU per Caco-2 cell. 
 
Figure 22: The results of two different experiments investigating the effect of thiophenones on S.epidermidis 
RP62A adherence to eukaryotic Caco-2 cells. 
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4.6 Infection in C.elegans 
To find out whether any of the tested bacterial strains were pathogenic to C.elegans, living 
and dead worms were registered for 7 days after infection with the different bacterial strains. 
The mean of live worms in each of the 6-wells varied from 13-20 worms, Fig.23. 
 
Figure 23: Mean live worms in each well for the different infection plates and control at day of infection. 
 
At day seven the number of dead worms in each infection plate was compared to the amount 
of live worms at the time of infection (Fig.24). In the control plate containing E.coli OP50 the 
mean number of dead worms was 21.9%. In the infection plate containing S.aureus ATCC 
1694 the mean number of dead worms was the highest, 38.5%. There were also visual 
differences between the dead worms which had been feeding on S.aureus compared to the 
other plates. The dead worms were more difficult to spot, because they became almost 
completely transparent with only the outline showing, and several of them had a rupture in the 
vulva area. It is worth noticing that the percentage of dead worms was lowest in the plates 
containing S.epidermidis RP62A and ATCC 155, the percentages of dead worms were both 
lower than the E.coli:OP50 control plate. It was decided to carry out an experiment to look at 
the effect of thiophenones on S.aureus infection in C.elegans.  
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Figure 24: Percentage of dead worms for each of the different infection plates after 7 days of infection.  
4.6.1 Effect of thiophenones on infection in C.elegans 
Recovery of worms infected with S.aureus was followed for 7 days after initial infection. The 
number of worms was counted at the start of the recovery experiment (Fig.25). The number of 
worms in each well varied from only 4 to 32 at most. Mean fewest worms was found in the 
wells were the effect of TF310 on recovery of worms infected by S.aureus was being assayed.  
 
Figure 25: Mean number of worms in the different wells. Black bars indicate wells were the effect of TF310 on 
recovery was assayed. Error bars represent standard error 
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Number of live and dead worms in each well was registered every 24 h for 7 days after 
infection. The percentage of dead worms in each well was calculated. Fig.26 shows the mean 
percentage of dead worms for each of the samples tested, at day seven after initial infection. 
Fewest dead worms were found in the wells where E.coli:OP50 fed worms were kept in BHI-
M9 media. Worms grown in 2.5P media showed higher percentage of death, but this 
difference was not found to be statistically significant (One way ANOVA). There were not 
any statistical significant difference between worms infected by S.aureus kept in 2.5P media 
and worms fed with E.coli kept in 2.5P media (One way ANOVA). No difference was found 
between infected worms kept in 2.5P media supplemented with TF310, and infected worms 
kept in 2.5P without TF310. The highest percentage of dead worms were found among worms 
kept in BHI-M9 media supplied with TF310, but no statistically significant difference was 
found when compared to worms kept in BHI-M9 without TF310 (One way ANOVA).  
Results seem to be due to random sampling variability. 
 
Figure 26: Mean percentage of dead worms in each of the samples. Black bars indicate worms grown in media 
supplemented with TF310. Error bars represents standard error between the wells in each sample.  
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5 Discussion 
5.1 Thiophenones as quorum sensing inhibitors 
The ability of thiophenones 310 and 101 to repress bioluminescence by inhibiting AI-2 
mediated communication in V.harveyi reporter strains has been shown in several studies (113, 
130, 132). In this study the ability of TF301 and TF403 to repress bioluminescence was 
assayed in V.harveyi MM32, an AI-2 reporter strain, together with TF310 and TF101. All 
thiophenones used in this study repressed bioluminescence induced by DPD by more than 
83% at a concentration of only 2.5µM.  
5.1.1 AI-2 based quorum sensing in S.epidermidis 
S.epidermidis RP62A has been sequenced and shown to have the gene for AI-2 synthase, luxS 
(Fig.5). It was therefore interesting to test if a cell-free supernatant prepared from 
S.epidermidis culture could induce bioluminescence in V.harveyi MM32 and to look at the 
effect of thiophenones in inhibiting bioluminescence. The attempt to induce bioluminescence 
by adding a cell-free S.epidermidis supernatant to MM32 was unsuccessful. The experiment 
was repeated several times with supernatants prepared from different time points, 4 h, 6 h and 
16 h of growth, and from different culture media, TSB, HI and BHI. At the same time, 
bioluminescence induction by DPD was successful. The reason for this could be that the 
concentration of the AI-2 signaling molecule in the supernatant was too low to induce 
bioluminescence in the reporter, or that there was no AI-2 production. The time points for 
preparing the supernatants was influenced by a study on another S.epidermidis strain, 1457, 
that shows that AI-2 production is highest in logarithmic phase, 4-6 h of growth (112).  But 
there could of course be different properties in AI-2 production between these two strains. 
S.epidermidis RP62A cell-free supernatant, prepared after growth overnight in BHI, has in 
another study been shown to be capable of inducing bioluminescence in a slightly different 
V.harveyi AI-2 reporter strain, BB170 (126). The difference between MM32 and BB170 , is 
that BB170 has AI-2 production of its own, but when used in bioluminescence assay 
induction of luminescence in addition to BB170 own baseline production is studied (137, 
138). It is therefore a possibility that the concentration of AI-2 in the S.epidermidis RP62A 
supernatant is not high enough to induce bioluminescence when there is no AI-2 production in 
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the reporter strain, but the concentration is high enough to add to the effect of an AI-2 
concentration already near threshold for the induction bioluminescence.  
5.2 Thiophenones and biofilm formation 
The effect of quorum sensing inhibitors like furanones and thiophenones against biofilm 
formation has been thoroughly documented in many studies with both gram positive and gram 
negative bacteria (122, 132, 139, 140). The same has also been shown for both thiophenone 
and furanone in S.epidermidis strain RP62A (ATCC 35984), the same as being used in this 
study (113, 125, 126). The effect of TF101, TF301, TF310 and TF403 on biofilm formation in 
S.epidermidis RP62A was investigated, with unexpected results. TF403 increased biofilm 
formation compared to the control, but a small effect could be seen for the other 
thiophenones. However, none of these results were statistically significant compared to the 
control. TF101 and TF310 at the same concentration, 5µM, have earlier been reported to 
inhibit biofilm formation in RP62A with 56% and 59%, respectively (113). Different from 
this study, culture was prepared in BHI and biofilm was allowed to form with shaking for 6 h, 
instead of in TSB and without shaking for 6 h. In this thesis the total amount of biofilm 
formed in the control samples was higher, with an OD530nm reaching 2.2 after 6 h, compared 
to around 1.5 for the previous study. The different experimental conditions between the two 
studies could possibly be the reason for the increased biofilm formation and the decreased 
effect of the thiophenones found here. This is the first experiment showing the effect of 
TF403 on biofilm formation in S.epidermidis. TF403 was as effective as the other 
thiophenones tested in inhibiting bioluminescence in V.harveyi MM32, but had a positive 
effect on biofilm formation. It is difficult to find an explanation for this, but increased biofilm 
formation of a luxS mutant constructed from S.epidermidis strain 1457 have previously been 
reported and explained by negative regulation of PIA-production by luxS (112). It is a 
possibility that TF403 inhibits AI-2 communication by a different mechanism than the other 
thiophenones tested, and as a result leads to increased biofilm formation.  
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5.2.1 Combined effect of thiophenones and antibiotics 
The effect of thiophenones in combination with levofloxacin was tested at the same time as 
the effect of the different thiophenones alone. No additive effect of thiophenones in 
combination with levofloxacin compared to levofloxacin could be detected, but this is not 
surprising when we look at the poor effect that thiophenones alone had in inhibiting biofilm 
formation in this study. It is also worth mentioning the fact that the levofloxacin 
concentrations tested were all above the MIC-level, and still there were quite a lot of biofilm 
forming and planktonic growth (results for growth not shown).  One of the reasons for this 
could be that working with such low concentrations and such small volumes of antibiotic 
solution, increases the risk of inaccuracy, and the possibility that the concentration of 
antibiotic in each well is below the effective concentration. 
5.3 Persister cells 
Persister cells were successfully isolated from lag phase to late exponential phase. As 
antibiotic treatment risks selecting for antibiotic resistant bacteria, the MIC of the isolated 
cells was tested to confirm that their survival was due to persistence and not resistance. The 
MIC of isolated persister was higher than for the initial testing, but according to the European 
Committee on Antimicrobial Susceptibility testing (Eucast) breakpoint tables for 
interpretation of  MICs and zone diameters (2012), MIC-values above 2µg/ml indicate 
resistance  against levofloxacin for Staphylococcus species (141).  In accordance with data 
obtained in another study on S.epidermidis RP62A, a persister population was isolated after 
treatment of high concentrations of levofloxacin (45). At most, a persister population of 
4.6x10
6 
CFU/ml was isolated, constituting 0,054% of the original culture. 
5.3.1 Quorum sensing inhibition and persister cells 
In this thesis an aim was to establish a method for persister isolation and to test the effect of 
different thiophenones on the formation of persister cells in S.epidermidis during growth, and 
if it had effect on persister cells tolerance to antibiotic.  Based on the results, no conclusion 
could be drawn on the effect of thiophenones, neither during growth nor together with 
antibiotics. In some of the experiments addition of thiophenones showed increased persister 
formation/survival, in other experiments the results were opposite. Isolating persisters can be 
difficult, because they resume regular growth after removal of antibiotic. This was tried to be 
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circumvented by working quickly and using cold medium for the dilution and plating out 
process. Nevertheless, this could be a possible factor leading to the non-reproducible results.  
Another reason could be that the colony counting method to calculate CFU/ml is not 
sufficiently sensitive and that in many of these experiments very few colonies in each spot 
were counted, which give increased risk of inaccurate results. The differences observed in 
some of the experiments between untreated and treated samples could therefore be due to 
chance. It would be necessary to optimize the method for calculation of persister number, and 
to repeat the experiments more than two times to be able to make any reliable conclusion. 
 During the last years one group has in several studies reported that different furanones 
are able to sensitize E.coli and P.aeruginosa persister cells to antibiotic (127, 128, 142, 143). 
In these studies effects of the furanone was assayed using a different method. They isolated 
the persister cells before adding the selected furanone and incubated for a selected period of 
time, followed by a second persister isolation. In other words, they tested the effect of 
furanone on antibiotic sensitivity on already formed persister, while here we investigated the 
effect of thiophenones on development of persister cells in a growing culture or in a culture 
challenged with antibiotics. This could be the reason for the differences in the results on the 
QS-inhibitors effect on persister cells. One of the thiophenones used in this study, TF403, was 
also the structural homologue of the furanone used in the studies in E.coli and P.aeruginosa 
persister cells, BF8, but without proving to have any effect on the amount of surviving 
persisters in culture. Whether or not persister cell formation is under quorum-sensing control 
remains unclear. QS-signaling molecules and stationary phase cell-free cultures have shown 
to increase persister cell number in P.aeruginosa (144). In the study on E.coli persister cells, 
the same effect of the furanone was reported in a luxS mutant, showing that the furanone 
might have other targets than AI-2 quorum sensing (127).  Optimization of the method is still 
needed to conclude on the effect of thiophenones on persister cell development and survival.  
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5.4 Adhesion to eukaryotic cells 
An important step in both bacterial pathogenesis and biofilm formation on implant surfaces is 
the ability to adhere to host cells (29, 145). It was therefore of interest to test the effect of 
thiophenones in bacterial adherence to eukaryotic cells. No effect of thiophenones could be 
seen in the two experiments performed. The first experiment could give an indication of 
thiophenones leading to increased binding, but these results were not reproducible in a second 
experiment.  Over-all, there were few bacteria adhering to each cell, less than a 0.25 bacteria 
binding to each eukaryotic cell, at most. One of the obvious reasons for this is that 
S.epidermidis is not associated with gut infections, and that another cell line than Caco-2 
should be used, which are colon cancer cells. It would therefore be more relevant to test 
S.epidermidis ability to bind to skin or mucosal cells, and the effect of thiophenones in such 
an experiment. Studies of S.epidermidis on adherence to other cell-lines have been conducted. 
One study have shown that S.epidermidis RP62A bind to human umbilical vein endothelial 
cells (HUVEC),  and that about 5.6 % of the inoculum bound to the cells in those experiments 
(146). In comparison, 0.11 % and 0.0056 % of the inoculum was found to bind to the Caco-2 
cells in this study. In the experiment with adherence to HUVEC the highest percentage of 
adherence was found after 3 h incubation, while we only used 90 min of incubation. Another 
factor to be considered is the colony counting method. 25µL drops were plated out in one of 
the experiments, and about 1-3 colonies after a 10
-1
 dilution was obtained, which does not 
give an accurate calculation of CFU/ml. It would also be of relevance to study the effect that 
thiophenones alone had on the cells tested, to see if they for instance were toxic to the cells.  
5.5 C.elegans as a model for infection studies 
C.elegans is an economical and easy model used to study microbial infections. The first step 
was to establish whether any of the selected strains were pathogenic to C.elegans. Among the 
tested strains, S.aureus ATCC1694 led to the highest mortality compared to control and other 
strains tested. This is in line with studies showing that several S.aureus strains lead to 
infection in C.elegans (147). Fewer worms died when fed on the S.epidermidis strains 
compared to control. There were also fewer worms, on average in these wells compared to the 
control. The higher survival of worms in the samples with the lowest number of worms in 
each well might indicate that worm survival is influenced by stress. This could also bias the 
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result showing that S.aureus led to the highest percentage of death, because the worms 
feeding on S.aureus were also kept in the most crowded environment (Fig.23).   
5.5.1 The effect of thiophenones on infection in C.elegans 
The effect of thiophenones on C.elegans recovery from infection by S.aureus was 
investigated in an experiment. No conclusion could be drawn based on the results from this 
experiment. First of all, S.aureus did not seem to have any effect on C.elegans survival, 
compared to worms fed on E.coli:OP50. In the previous experiment where the ability to 
different Staphylococcal strains to cause disease and mortality in C.elegans was studied, 
worms was infected for 7 days, and S.aureus was shown to decrease worm survival. In this 
experiment infection was only carried out for 24 h, before the worms were moved to media 
supplied with E.coli:OP50. It could indicate that 24 h is too little time for S.aureus to cause a 
persistent infection in C.elegans. There was also a high variance in the number of worms in 
each well, and that makes it difficult to draw any conclusion regarding the effect of 
thiophenones on the worm’s recovery from infection. When comparing uninfected worms 
kept in media with or without thiophenone, no statistically significant difference could be 
detected. This indicates that 5µM TF310 is not toxic to the worm. In a study where the effect 
of different compounds against S.aureus infection in C.elegans was studied, the worms were 
fed on S.aureus in the liquid media during the whole experiment (148). They also used a 
different strain of S.aureus, causing 100% death of the worms after 4-5 days (148). A more 
even distribution of the worms in the wells and a longer period of infection prior to the 
recovery study, or the use of another S.aureus strain, will be needed to determine if TF310 
has the ability to clear an infection in C.elegans.    
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6 Future studies 
 Confirm AI-2 production in S.epidermidis by a different method than the 
bioluminescence assay. 
 Test the effect of thiophenones on biofilm formation in combination with the other 
antibiotics S.epidermidis showed susceptibility for; novobiocin, linezolid and 
vancomycin.  
 Find a way to optimize persister quantification, to be able to compare persister 
formation in cultures grown with or without thiophenones. Use novobiocin, linezolid 
and vancomycin in isolation experiment, and test the effect of thiophenones in 
combination with these. Experiment also needs to be repeated several times, to obtain 
more conclusive results. 
 Test the effect of thiophenones on S.epidermidis adherence to eukaryotic cells using a 
cell-line having a more natural implication on S.epidermidis infection.  
 Optimize infection studies in C.elegans, to be able to study the effect of thiophenones 
on recovery from S.aureus infection.  This could be done by infecting the worms for a 
longer period of time than 24 h before recovery studies, or repeat the experiment using 
a S.aureus strain shown to be more virulent against C.elegans.  
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Supplementary 
M9-buffer 
 
 
 
 
 
The buffer was autoclaved for 15 min at 121°C, and 500µl 1M MgSO
4 
pH4 was added right 
before use. 
Nematode growth medium (NGM)-plates 
8.5g  Agar 
1.25g Peptone 
1.5g NaCl 
487ml d
2
H2O 
The NGM-solution was autoclaved for 15 min at 121°C and cooled down to 56°C in a water 
bath. Right before it was poured on to the plates, the following was added: 
12.5ml 1M CaCl2 
500µl Cholesterol, 5mg\ml 
500µl 1M KH2 pH4 
500µl 1M MgSO
4 
 
1.5g   1M KH
2 
pH 4 
3g 1M Na2H(1?) 
2.5g NaCl 
500ml d
2
H2O 
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BHI20- Infection plates 
4.5g Agar 
1.85g BHI 
1.5g Peptone 
0.1g NaCl 
244ml d
2
H2O 
 
The solution was autoclaved for 15 min at 121°C, and cooled down to 56°C in a water bath. 
Before pouring 5ml of the solution into each well of a 6-well plate, the following was added: 
5ml 1M CaCl2 
200µl Cholesterol, 5mg\ml 
200µl 1M KH2 pH4 
200µl 1M MgSO
4 
Optimized Buffered Peptone Water (2.5P-media) 
1.25g Peptone 
1.50g NaCl 
1.75g Disodium phosphate 
0.75g Postassium dihydrogen phosphate 
500ml d
2
H2O 
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The solution was autoclaved for 15 min at 121°C, and cooled down before the following was 
added: 
500 µl CaCl2(1 M) 
500 µl Cholesterol (5mg/ml) 
500 µl MgSO4 (1 M) 
 
BA-medium for bioluminescence assay 
4.39g/0.3M NaCl 
3.01g/0.05M MgSO
4
 
0.5g/0.2% Casamino acid 
250ml d
2
H2O 
 
pH was calibrated to pH 7.5 with 1M KOH, and it was autoclaved for 15 min at 121°C. 
 
After the medium was cooled down the following was added: 
 
0.34g in 2.5ml d
2
H2O 1M Potassiumphosphate diHydrogen 
0.0435g in 2.5ml d
2
H2O 0.1M L-arginine 
2.5ml  Glycerol 
The medium was prepared right before an experiment and the rest was kept in a -80°C freezer 
to keep it fresh. 
Before inoculation of bacteria 0.1g riboflavin in 10ml d
2
H2O and 0.05g thiamine in 10ml 
d
2
H2O was sterile filtrated with a 0,2μm celluloseacetate filter (Whatman
®
) and diluted 500 
and 10 times, respectively, and 1µl\ml of each was added to the medium.  
